Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTK787 and Pemetrexed +/- Cisplatin in advanced NSCLC and mesothelioma
NCT00281125Phase 2Terminated
- Sponsor
- Nevada Cancer Institute
- Start
- Jan 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in non-small cell lung cancer (NSCLC), malignant pleural mesothelioma (MPM), sponsored by Nevada Cancer Institute. Started Jan 2006; status: terminated.
02
Drugs
vatalanib
03
Conditions
non-small cell lung cancer (NSCLC)malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00281125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281125.